Dr Larry Altstiel is chief medical officer of ProMIS Neurosciences and has decades of medical expertise in neurodegenerative diseases and experience in the pharmaceutical industry. As the former vice president and head of neuroscience clinical research at Pfizer, Larry led the selection of drug candidates, development and oversight of multiple studies focused on Alzheimer’s Disease.
See our Cookie Privacy Policy Here
